Initiating PrEP | May 21, 2021
Date of Presentation: April 21, 2021
Type: Past Presentation
Audience: Clinical
Program: PrEP (Pre-Exposure Prophylaxis)
Keywords: #pre-exposure prophylaxis #prep #prep initiation
In this presentation, Jorge Mera, MD, FACP, ECHO faculty member, infectious disease physician and director of Infectious Diseases at Cherokee Nation Health Services, shares valuable insights around clinical/laboratory evaluation prior to prescribing PrEP, rational for labs, interpretation of HIV and HBV serology, treatment considerations, discusses counseling prior to and during PrEP delivery, recommended regimens, and potential side effects from PrEP.
Recording:
Presented by:
Dr. Jorge Mera
Jorge Mera, MD, FACP, is the Director of Infectious Diseases for Cherokee Nation Health Services (CNHS), the largest tribally operated health care system in the United States. He completed his fellowship in Infectious Diseases and Clinical Microbiology at Baylor College of Medicine in Houston, Texas and is Board Certified by the American Board of Internal Medicine (ABIM) in Infectious Diseases. During recent years Jorge’s efforts have been dedicated to organizing the Cherokee Nation HCV elimination program, as well as the HIV/HCV ECHO project. He is also the Director of the HIV clinic since 2012 and the Principal Investigator of the End the HIV Epidemic for the CNHS. He is a Clinical Assistant Professor in the Department of Internal Medicine of the Oklahoma State University Health Science Center and a Fellow of the American College of Physicians.
Resources Provided:
- Patient Evaluation Before Initiating PrEP (Presentation Slides)
- CDC Draft 2021 Update to the HIV Preexposure Prophylaxis Clinical Practice Guideline and Supplement (Webinar; CDC)
Date added: May 21, 2021